Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation

Abstract

TACE+sorafenib was more effective than TACE or sorafenib alone in HCC BCLC stages B or C with a significant survival benefit and improved tumour regression especially in BCLC-C patients.